Bradley Burnam
Vermögen: 115 Mio $ am 30.06.2026
Vermögen: 115 Mio $ am 30.06.2026
Bradley Burnam is the founder of Turn Therapeutics, Inc., founded in 2015, holding the title of Chairman & Chief Executive Officer.
Mr. Burnam is also the founder of Turn Therapeutics (TM), Inc...
Mr. Burnam currently holds the position of Director at Baropace, Inc., starting in 2020.
Education history includes graduate studies at Stanford University and undergraduate studies at the University of California, Los Angeles.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TURN THERAPEUTICS INC. 52.76% | 28.05.2026 | 15’716’260 ( 52.76% ) | 115 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TURN THERAPEUTICS INC. | Vorstandsvorsitzender | 06.01.2015 |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Vorstandsvorsitzender | 01.01.2015 |
Baropace, Inc.
Baropace, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable devices intended for cardiac health monitoring | Direktor/Vorstandsmitglied | 01.12.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baropace, Inc.
Baropace, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable devices intended for cardiac health monitoring | Electronic Technology |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Health Technology |
Global Health Solutions Inc
Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen